May 17, 2018 / 10:51 PM / 9 days ago

Australia's CSL lifts full-year profit outlook

May 18 (Reuters) - Biotherapeutics company CSL Ltd on Friday lifted its full-year profit guidance for a second time this year, thanks to better-than-expected product sales.

CSL now expects net profit after tax for fiscal 2018 in the range of about $1.68 billion to $1.71 billion, from an earlier forecast of $1.55 billion to $1.60 billion, it said in a statement. (Reporting by Chris Thomas in Bengaluru Editing by Leslie Adler)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below